Fryns-Smeets-Thiry syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2058Q87.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Fryns-Smeets-Thiry syndrome is an extremely rare genetic condition that affects multiple body systems. It was first described in the medical literature by Fryns, Smeets, and Thiry, and is sometimes referred to by its Orphanet designation (ORPHA:2058). The syndrome is characterized by a combination of skeletal abnormalities, intellectual disability, and distinctive facial features. Affected individuals may have short stature, abnormalities of the hands and feet, and unusual facial characteristics such as a broad nasal bridge or other midface differences. Intellectual disability can range from mild to moderate, and some individuals may also experience delays in speech and motor development. Because this condition is so rare, with only a handful of cases reported in the medical literature, our understanding of the full range of symptoms and the best approaches to treatment remains limited. There is currently no cure or specific targeted therapy for this syndrome. Management is supportive and focuses on addressing individual symptoms, such as physical therapy for motor delays, speech therapy for communication difficulties, and educational support for learning challenges. Regular follow-up with a team of specialists is important to monitor growth, development, and any emerging medical concerns.

Key symptoms:

Intellectual disabilityShort statureDistinctive facial featuresBroad nasal bridgeAbnormalities of the handsAbnormalities of the feetDelayed speech developmentDelayed motor milestonesSkeletal abnormalitiesLow muscle tone

Clinical phenotype terms (19)— hover any for plain English
Disproportionate tall statureHP:0001519Patellar aplasiaHP:0006443
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Fryns-Smeets-Thiry syndrome.

View clinical trials →

No actively recruiting trials found for Fryns-Smeets-Thiry syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Fryns-Smeets-Thiry syndrome community →

No specialists are currently listed for Fryns-Smeets-Thiry syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Fryns-Smeets-Thiry syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Fryns-Smeets-Thiry syndromeForum →

No community posts yet. Be the first to share your experience with Fryns-Smeets-Thiry syndrome.

Start the conversation →

Latest news about Fryns-Smeets-Thiry syndrome

No recent news articles for Fryns-Smeets-Thiry syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific features led to this diagnosis, and could genetic testing help confirm it?,What therapies (physical, speech, occupational) should we start, and how often?,What developmental milestones should we be watching for, and when should we be concerned?,Are there any other medical complications we should screen for regularly?,What educational supports or accommodations would benefit my child?,Is genetic counseling recommended for our family regarding future pregnancies?,Are there any research studies or registries we can participate in?

Common questions about Fryns-Smeets-Thiry syndrome

What is Fryns-Smeets-Thiry syndrome?

Fryns-Smeets-Thiry syndrome is an extremely rare genetic condition that affects multiple body systems. It was first described in the medical literature by Fryns, Smeets, and Thiry, and is sometimes referred to by its Orphanet designation (ORPHA:2058). The syndrome is characterized by a combination of skeletal abnormalities, intellectual disability, and distinctive facial features. Affected individuals may have short stature, abnormalities of the hands and feet, and unusual facial characteristics such as a broad nasal bridge or other midface differences. Intellectual disability can range from m

How is Fryns-Smeets-Thiry syndrome inherited?

Fryns-Smeets-Thiry syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Fryns-Smeets-Thiry syndrome typically begin?

Typical onset of Fryns-Smeets-Thiry syndrome is neonatal. Age of onset can vary across affected individuals.